Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCLA
Dates
study started
completion around
Principal Investigator
by Igor Barjaktarevic, MD, PhD (ucla)
Headshot of Igor Barjaktarevic
Igor Barjaktarevic

Description

Summary

The objective of ILAN is to assess the safety, feasibility and bronchodilator efficacy of in-line bronchodilator nebulizer delivery with VMN via HFNC system in hypoxemic respiratory failure patients treated with bronchodilators and compare this method to standard-nebulization using a jet nebulizer with a facial mask. The investigators hypothesized that aerosol nebulization using HFNC/VMN represents safer and more convenient approach in hypoxemic respiratory failure patients in comparison to conventional therapy while providing similar bronchodilator efficacy.

Details

Keywords

Hypoxemic Respiratory Failure, Airway Obstruction, Respiratory Insufficiency, nebulizer via in-line drug delivery maintaining high-flow nasal cannula oxygen

Eligibility

Locations

  • Ronald Reagan Medical Center at UCLA accepting new patients
    Los Angeles California 90095 United States
  • Santa Monica UCLA accepting new patients
    Santa Monica California 90404 United States

Lead Scientist at University of California Health

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT05880836
Study Type
Interventional
Participants
Expecting 40 study participants
Last Updated